Target intelligence / Profile preview

Defensin beta 108 pseudogene 5 (DEFB108F)

Target
DEFB108F
Molecular classification
Other, Antimicrobial peptide, Defensin
01

Overview

Defensin beta 108F (DEFB108F, also known as DEFB108P5 or beta-defensin 108B-like) is a gene locus annotated as a pseudogene in the human genome. Pseudogenes such as DEFB108F are non-functional segments of DNA that closely resemble genes encoding beta-defensins, a family of small, cysteine-rich antimicrobial peptides involved in innate immunity. Functional beta-defensins are known to disrupt microbial membranes and contribute to defense against infection, but DEFB108F shows no evidence of protein expression or biological activity and is not considered a protein-coding therapeutic target, disease biomarker, or direct druggable entity. Beta-defensins as a class are well-studied for roles in antimicrobial defense. DEFB108F is part of a rapidly evolving, duplicated multigene family; many human DEFB genes are pseudogenes. No protein structure, peptide data, or functional assays for DEFB108F exist in the literature, distinguishing it from functionally-validated beta-defensins like beta-defensin 2 (DEFB4A) or hBD-2. DEFB108F is a defensin beta pseudogene without established functional protein product, biological role, or druggability. It is an example of the genomic complexity and rapid evolution of the beta-defensin gene family, with many human defensins being non-functional duplicates or pseudogenes.

Other names
DEFB108P5Beta-defensin 108B-likeDefensin beta 108 pseudogene 5DEFB108F

Beyond the preview

Go deeper on Defensin beta 108 pseudogene 5 (DEFB108F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defensin beta 108 pseudogene 5 (DEFB108F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call